ATE285793T1 - Rhodaminderivate für die photodynamische diagnose und behandlung - Google Patents

Rhodaminderivate für die photodynamische diagnose und behandlung

Info

Publication number
ATE285793T1
ATE285793T1 AT00965683T AT00965683T ATE285793T1 AT E285793 T1 ATE285793 T1 AT E285793T1 AT 00965683 T AT00965683 T AT 00965683T AT 00965683 T AT00965683 T AT 00965683T AT E285793 T1 ATE285793 T1 AT E285793T1
Authority
AT
Austria
Prior art keywords
treatment
rhodamine derivatives
derivatives
photodynamic diagnosis
photodynamic
Prior art date
Application number
AT00965683T
Other languages
English (en)
Inventor
Denis-Claude Roy
Martin Guimond
Nestor A Molfino
Original Assignee
Univ Montreal
Hopital Maisonneuve Rosemont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montreal, Hopital Maisonneuve Rosemont filed Critical Univ Montreal
Application granted granted Critical
Publication of ATE285793T1 publication Critical patent/ATE285793T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Aggression treatment or altering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT00965683T 1999-10-05 2000-10-03 Rhodaminderivate für die photodynamische diagnose und behandlung ATE285793T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15779099P 1999-10-05 1999-10-05
PCT/CA2000/001142 WO2001024824A1 (en) 1999-10-05 2000-10-03 Rhodamine derivatives for photodynamic diagnosis and treatment

Publications (1)

Publication Number Publication Date
ATE285793T1 true ATE285793T1 (de) 2005-01-15

Family

ID=22565296

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00965683T ATE285793T1 (de) 1999-10-05 2000-10-03 Rhodaminderivate für die photodynamische diagnose und behandlung

Country Status (12)

Country Link
EP (1) EP1267931B1 (de)
JP (3) JP4859319B2 (de)
KR (1) KR100697400B1 (de)
AT (1) ATE285793T1 (de)
AU (1) AU781855B2 (de)
BR (1) BR0014135A (de)
CA (2) CA2382885C (de)
DE (1) DE60017201T2 (de)
ES (1) ES2234668T3 (de)
MX (1) MXPA02003522A (de)
PT (1) PT1267931E (de)
WO (1) WO2001024824A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8409564B2 (en) 1999-10-05 2013-04-02 Universite De Montreal Rhodamine derivatives for photodynamic diagnosis and treatment
JP4647187B2 (ja) * 2001-04-02 2011-03-09 セルメド バイオサイエンシズ インコーポレイテッド ハロゲン化ローダミン誘導体およびその適用
CA2342675A1 (en) 2001-04-02 2002-10-02 Abdelkrim Habi Halogenated rhodamine derivatives and applications thereof
JP2005517637A (ja) * 2001-11-29 2005-06-16 セラコス・インコーポレイテッド 体外フォトフォレーシスおよび／またはアポプトーシス細胞による一定の被験体を前処理するための方法
AU2004294243B2 (en) * 2003-12-05 2011-02-17 Hopital Maisonneuve-Rosemont Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer
GB0912584D0 (en) * 2009-07-20 2009-08-26 Ucl Business Plc Cyclosporin conjugates
EP3058957A1 (de) 2015-02-19 2016-08-24 Kiadis Pharma Intellectual Property BV Verbessertes fotodynamisches Verfahren und daraus hergestelltes Produkt
RU2637279C2 (ru) * 2015-12-25 2017-12-01 Сергей Петрович Кречетов Способ фотодинамической терапии
TWI715927B (zh) * 2019-02-01 2021-01-11 國立清華大學 組合物用於製備治療癌細胞的藥物的用途
EP3730627A1 (de) 2019-04-25 2020-10-28 Kiadis Pharma Intellectual Property BV Verfahren zur überprüfung der spenderidentität
EP3769770A1 (de) 2019-07-23 2021-01-27 Kiadis Pharma Intellectual Property BV Verfahren zur hemmung oder prävention von infektionen bei einem transplantatempfänger
CN115960090B (zh) * 2022-12-30 2024-03-29 中山大学 一种罗丹明b修饰吡啶配体的制备方法及其光催化抗菌应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321919A (en) * 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
EP0544895B1 (de) * 1991-06-21 1997-08-27 Baxter International Inc. Verfahren zur inaktivierung von pathogenen in einer körperflüssigkeit
US5807881A (en) * 1992-05-27 1998-09-15 Quadra Logic Technologies, Inc. Method for selectively reducing activated leukocyte cell population
US5556992A (en) * 1994-09-02 1996-09-17 Universite De Montreal Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias
EP0935462B1 (de) * 1996-03-29 2005-07-27 Therakos, Inc. Behandlung von leukocyten durch photopheresis
CA2270558C (en) * 1996-11-06 2006-08-15 Meiji Seika Kaisha, Ltd. Treatment of autoimmune diseases by photochemotherapy
JP2003520563A (ja) * 1997-07-21 2003-07-08 シーラス コーポレイション 白血球を処置する方法、白血球組成物およびそれを使用する方法
AU747753B2 (en) * 1997-08-05 2002-05-23 Meiji Seika Kaisha Ltd. Immunosuppression by photochemotherapy
WO1999028486A1 (en) * 1997-12-04 1999-06-10 Duke University Methods of isolating and using cd7+cd34-lin-hematopoietic cells

Also Published As

Publication number Publication date
CA2382885A1 (en) 2001-04-12
KR100697400B1 (ko) 2007-03-20
EP1267931B1 (de) 2004-12-29
JP2011229537A (ja) 2011-11-17
JP4859319B2 (ja) 2012-01-25
DE60017201D1 (de) 2005-02-03
KR20020050234A (ko) 2002-06-26
WO2001024824A1 (en) 2001-04-12
JP2003510372A (ja) 2003-03-18
JP5476342B2 (ja) 2014-04-23
CA2699662A1 (en) 2001-04-12
MXPA02003522A (es) 2004-09-10
PT1267931E (pt) 2005-05-31
CA2382885C (en) 2010-06-29
JP2011093939A (ja) 2011-05-12
EP1267931A1 (de) 2003-01-02
AU781855B2 (en) 2005-06-16
BR0014135A (pt) 2002-05-21
AU7635700A (en) 2001-05-10
DE60017201T2 (de) 2005-12-29
ES2234668T3 (es) 2005-07-01

Similar Documents

Publication Publication Date Title
DE60017201D1 (de) Rhodaminderivate für die photodynamische diagnose und behandlung
GR1000611B (el) Μεθοδος για την παρασκευη οφθαλμικων συνθεσεων κυκλοσπορινης.
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
ATE229815T1 (de) In vitro methoden und verwendung von pharmazeutische zusammensetzungen für die behandlung von innenohrhaarzellen
ES2149971T3 (es) Derivados 5-sustituidos del acido micofenolico.
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
ECSP066311A (es) Derivados de la piperazina y su uso como agentes terapéuticos
NZ529682A (en) Biologically active methylene blue derivatives
ES2191068T3 (es) Tratamiento profilactico y terapeutico de la sensibilizacion e irritacion de la piel.
DE60022754D1 (de) Diagnose und behandlung von arrhythmien
ATE250576T1 (de) Substituierte pyrrolylverbindungen zur behandlung von entzündungen
ES2150157T3 (es) Piridinas 2-aril sustituidas.
DE69927823T2 (de) Hydrogel für die therapeutische behandlung von aneurysmas
ES2169127T3 (es) Nuevos carbamatos y ureas como modificadores de la resistencia multi-farmaco.
DE59611341D1 (de) Verwendung von saccharid-konjugaten
ES2160173T3 (es) Nuevo derivado de rodamina para la terapia fotodinamica de cancer y purgacion en vitro de leucemia.
TR200402628T4 (tr) Androjenetik ve yaygın alopezinin tedavisinde melatonin maddesinin kullanımı
DK1381611T3 (da) Metalsubstituerede ikke-centrosymmetriske phthalocyaninanaloger, fremstilling heraf og anvendelse i fotodynamisk terapi samt in vivo diagnostik
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
DE60001555D1 (de) Wässrige lösung zum konservieren von gewebe und organen
WO2001024825A3 (en) Significance of dosimetry in photodynamic therapy of injured arteries
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
WO2000061124A3 (en) Use off cell membrane penetrating indigoid bisindole derivatives
DE60128932D1 (de) Photosensibilisatoren
BG50159A3 (bg) Метод за получаване на производни на пиранобензоксадиазол

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1267931

Country of ref document: EP